High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$101K
$101,360
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
PLX
P
Protalix BioTherapeutics, Inc.
Bashan Dror
• CEO
Discretionary BuyΔOwn +42.3%
2025-12-19
$101,360
|
||||||
| PLX |
Protalix BioTherapeutics, Inc.
|
CEO
Discretionary BuyΔOwn +42.3%
|
2025-12-19 | $101,360 | P | Form 4 |